Ping Chong Bee

1.0k total citations
58 papers, 461 citations indexed

About

Ping Chong Bee is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ping Chong Bee has authored 58 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 18 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Ping Chong Bee's work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ping Chong Bee is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ping Chong Bee collaborates with scholars based in Malaysia, United Kingdom and Singapore. Ping Chong Bee's co-authors include Gin Gin Gan, Zahurin Mohamed, Shamsul Mohd Zain, Veera Sekaran Nadarajan, Li‐Chia Chen, Siew Siang Chua, Tan Seng Beng, Sean Chang, Maude E. Phipps and Kian Meng Chang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Ping Chong Bee

54 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Chong Bee Malaysia 12 151 99 84 70 66 58 461
Montserrat Briz Spain 14 215 1.4× 98 1.0× 158 1.9× 44 0.6× 89 1.3× 27 523
Lanh Green United States 5 56 0.4× 77 0.8× 46 0.5× 62 0.9× 92 1.4× 8 659
Wanda Górnik Poland 12 61 0.4× 98 1.0× 87 1.0× 92 1.3× 86 1.3× 25 508
Huihui Li China 16 162 1.1× 164 1.7× 131 1.6× 39 0.6× 19 0.3× 38 683
Carmen H. Tong United States 15 250 1.7× 183 1.8× 56 0.7× 28 0.4× 85 1.3× 32 1.1k
Song Ren China 13 229 1.5× 155 1.6× 82 1.0× 150 2.1× 130 2.0× 33 953
Hartmut Dietrich Germany 16 46 0.3× 70 0.7× 47 0.6× 34 0.5× 40 0.6× 40 655
E Mayayo Spain 13 49 0.3× 97 1.0× 19 0.2× 27 0.4× 90 1.4× 48 510
Rocío Prieto‐Pérez Spain 17 44 0.3× 34 0.3× 20 0.2× 30 0.4× 109 1.7× 21 591
Mila Tang Canada 9 54 0.4× 50 0.5× 37 0.4× 13 0.2× 57 0.9× 17 372

Countries citing papers authored by Ping Chong Bee

Since Specialization
Citations

This map shows the geographic impact of Ping Chong Bee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chong Bee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chong Bee more than expected).

Fields of papers citing papers by Ping Chong Bee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Chong Bee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chong Bee. The network helps show where Ping Chong Bee may publish in the future.

Co-authorship network of co-authors of Ping Chong Bee

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Chong Bee. A scholar is included among the top collaborators of Ping Chong Bee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Chong Bee. Ping Chong Bee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iyadorai, Thevambiga, Sun Tee Tay, Chandramathi Samudi, et al.. (2025). Incidence and Risk Factors for Invasive Fungal Infection in Patients with Hematological Malignancies at a Tertiary Hospital in Malaysia. Asian Pacific Journal of Cancer Prevention. 26(3). 839–845.
2.
4.
Kuo, Kevin H.M., Pranee Sutcharitchan, Ping Chong Bee, et al.. (2023). Efficacy and Safety of Luspatercept in Patients with HbE/β-Thalassemia from the BELIEVE Study: A Subgroup Analysis. Blood. 142(Supplement 1). 3848–3848. 1 indexed citations
5.
Bee, Ping Chong, et al.. (2023). CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country. Indian Journal of Hematology and Blood Transfusion. 40(1). 97–102. 2 indexed citations
6.
Gan, Gin Gin, Sumaiyah Mat, Marniza Saad, et al.. (2022). Quality of Life of Family Caregivers of Cancer Patients in a Developing Nation. Asian Pacific Journal of Cancer Prevention. 23(11). 3905–3914. 5 indexed citations
7.
Bee, Ping Chong, et al.. (2021). Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review. Patient Preference and Adherence. Volume 15. 2563–2575. 12 indexed citations
8.
Gan, Gin Gin, et al.. (2020). Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia. PubMed. 3(3). 44–47. 1 indexed citations
9.
Bee, Ping Chong, et al.. (2020). Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non‐hodgkin lymphoma: A retrospective analysis in a resource‐limited country. International Journal of Clinical Practice. 75(3). e13823–e13823. 1 indexed citations
10.
Liew, Su May, et al.. (2019). Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis. Critical Reviews in Oncology/Hematology. 144. 102818–102818. 16 indexed citations
11.
Gan, Gin Gin, et al.. (2019). <p>Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study</p>. Patient Preference and Adherence. Volume 13. 1363–1373. 23 indexed citations
13.
Lim, Shen‐Yang, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.. (2018). A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy. Journal of Movement Disorders. 11(2). 89–92. 14 indexed citations
15.
Gan, Gin Gin, et al.. (2014). Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. Tumor Biology. 36(3). 1819–1834. 5 indexed citations
16.
Gan, Gin Gin, et al.. (2014). Impact of Inadequate Doses of Rituximab in the Treatment of Diffuse Large B Cell Lymphoma in Malaysian Patients. Asian Pacific Journal of Cancer Prevention. 15(4). 1703–1706. 3 indexed citations
17.
Gan, Gin Gin, Shamsul Mohd Zain, Batoul Sadat Haerian, et al.. (2014). Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. Journal of Human Genetics. 59(5). 280–287. 6 indexed citations
18.
Nadarajan, Veera Sekaran, et al.. (2011). Lipocalin‐2 is associated with modulation of disease phenotype in a patient with concurrent JAK2‐V617F and BCR‐ABL mutation. European Journal Of Haematology. 88(2). 175–178. 3 indexed citations
20.
Gan, Gin Gin, et al.. (2010). Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations. Annals of Hematology. 90(6). 635–641. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026